Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
9.01
+0.28 (3.21%)
Mar 20, 2025, 4:00 PM EST - Market closed
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.79 billion as of March 21, 2025. Its market cap has increased by 70.61% in one year.
Market Cap
2.79B
Enterprise Value
5.27B
1-Year Change
70.61%
Ranking
Category
Stock Price
$9.01
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.79B, a decrease of -51.52%. That is a compound annual growth rate of -9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2025 | 2.79B | 13.81% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 751.78B |
| UnitedHealth Group | 460.28B |
| Johnson & Johnson | 392.78B |
| AbbVie | 374.70B |
| Novo Nordisk | 353.87B |
| Merck & Co. | 237.50B |
| AstraZeneca | 237.08B |
| Abbott Laboratories | 220.99B |